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Background: Ginseng, which is widely used in functional foods and as an herbal medicine, has been
reported to reduce the proliferation of prostate cancer cells by mechanisms that are not yet fully
understood.
Methods: This study was designed to investigate the changes in ginsenoside content in ginseng after
treatment with a microwave-irradiation thermal process and to verify the anticancer effects of the ex-
tracts. To conﬁrm the anticancer effect of microwave-irradiated processed ginseng (MG), it was tested in
three human prostate cancer cell lines (DU145, LNCaP, and PC-3 cells). Involvements of apoptosis and
autophagy were assessed using Western blotting.
Results: After microwave treatment, the content of ginsenosides Rg1, Re, Rb1, Rc, Rb2, and Rd in the
extracts decreased, whereas the content of ginsenosides 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5 increased.
Antiproliferation results for the human cancer cell lines treated with ginseng extracts indicate that PC-3
cells treated with MG showed the highest activity with an half maximal inhibitory concentration of
48 mg/mL. We also showed that MG suppresses the growth of human prostate cancer cell xenografts in
athymic nude mice as an in vivomodel. This growth suppression by MG is associated with the inductions
of cell death and autophagy.
Conclusion: Therefore, heat processing by microwave irradiation is a useful method to enhance the
anticancer effect of ginseng by increasing the content of ginsenosides Rg3, Rg5, and Rk1.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prostate cancer is a commonly diagnosed tumor in men that
represents a broad spectrum of severity, ranging from indolent to
highly lethal [1]. Because prostate cancer cannot grow or differ-
entiate without androgens, hormone therapy has become the
standard treatment for prostate cancer [2]. However, cancer
recurrence normally develops in years when the patient with
prostate cancer no longer responds to hormone therapy. Therefore,
chemotherapy with cytotoxic agents has been suggested as an
alternative growth inhibitor for hormone-refractory prostate cells
[3]. However, the effectiveness of cytotoxic agents against prostateorean Medicine, Gachon Universit
ung Institute of Natural Products, Ko
, ham0606@kist.re.kr (J. Ham).
ht  2015, The Korean Society of G
c-nd/4.0/).cancer cells is markedly diminished due to the slow proliferation of
these cells [4].
Several anticancer agents inhibiting proliferation of cancer cells,
inducing apoptosis, or modulating signal transductions are
currently used for the treatment of cancers, and a combination of
multiple chemopreventive agents with multiple targets is consid-
ered to be more effective [5]. Therefore, herbal therapy has been
suggested, partly because herbal medicines consist of several con-
stituents with multiple targets, and partly because there is a long
history of using herbal medicines in Asian and European countries
[6]. Natural products have appreciably contributed to the devel-
opment of a large number of anticancer drugs. Approximately 50%y, 1342 SeongnamDaero, Seongnam 461-701, Korea.
rea Institute of Science and Technology, 679 Saimdang-ro, Gangneung 210-340, Korea.
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products or natural product mimics and were developed based on
the knowledge obtained from small molecules or macromolecules
existing in nature [7e9].
Ginseng, generally the root of Panax ginseng Meyer, has been
used in Oriental medicine and is now used widely around the
world. There are a variety of commercial ginseng products avail-
able, such as white, red, sun, and black ginsengs [10,11]. More than
30 different ginsenosides have been identiﬁed and isolated, all with
several pharmacological effects. Ginsenosides are divided into
20(S)-protopanaxadiols (ginsenoside Rb1, Rb2, Rc, Rd, and Rg3) and
20(S)-protopanaxatriols (ginsenoside Re and Rg1) groups on the
basis of their aglycone moieties (Fig. 1) [11,12].
Recently, our group developed a novel ginseng extract by
microwave-assisted processing. This novel microwave-irradiated
processed ginseng (MG) extract has increased content of ginseno-
sides Rg3, Rg5, and Rk1 [13]. In this study, we demonstrate that MG
inhibits prostate cancer cell growth in three human prostate cancerFig. 1. Structures and analysis of ginsenosides. (A) Structures of ginsenosides contained in P
Rd) in processed ginseng by microwave. (C) HPLC chromatogram analyzing ginsenosides (
copyranosyl; -Rha, L-rhamnopyranosyl; -Ara(f), L-arabinofuranosyl; -Ara(p), L-arabinopyrancell lines (DU145, LNCaP, and PC-3 cells). Furthermore, we sought to
investigate the anticancer efﬁcacy of MG on the growth of prostate
cancer cells in vivo (as xenografts in athymic nude mice).
2. Materials and methods
2.1. Chemicals and reagents
DulbeccomodiﬁedEaglemedium(DMEM)and fetal bovine serum
(FBS)werepurchased fromInvitrogenCo. (Grand Island,NY,USA). EZ-
Cytox enhanced cell viability assay kit was purchased from ITSBIO
(Seoul, Korea). Ginsenoside standards Rb1, Rb2, Rc, Rd, Re, 20(S)-Rg3,
20(R)-Rg3, Rk1, and Rg5were purchased from Ambo Institute (Seoul,
Korea). Monoclonal antibodies against cleaved caspase-8 and b-actin
andpolyclonal antibodies against cleavedcaspase-3, cleaved caspase-
9, Bcl-2, Bax, and poly (ADP-ribose) polymerase (PARP) were pur-
chased from Cell Signaling Technology, Inc. (Danvers, MA, USA). The
water and acetonitrile usedwere of HPLC grade from Fisher Scientiﬁcanax ginseng. (B) HPLC chromatogram analyzing ginsenosides (Re/Rg1, Rb1, Rc, Rb2 and
20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5) in processed ginseng by microwave. -Glc, D-glu-
osyl.
J Ginseng Res 2016;40:62e6764(Pittsburgh, PA, USA) and glacial acetic acid was of analytical grade
from Sigma-Aldrich (Saint Louis, MO, USA).
2.2. Preparation of ginseng extract
Four-year-old fresh ginseng (Panax ginseng) was purchased from
a local ginseng market in Seoul (Korea). White ginseng was pre-
pared by drying 100 g of fresh ginseng at 50

C for 3 days. White
ginseng was ground to pass an 80-mesh sieve and extracted under
reﬂux with 50% ethanol three times at 70

C for 2 h, ﬁltered through
ﬁlter paper (Advantec, Tokyo, Japan), and the solvent was evapo-
rated in vacuo to give a 50% ethanol extract with a yield of about
20%, by weight, of the original ginseng powder.
2.3. Preparation of processed ginseng by using microwave
irradiation
The 50% ethanol extract of ginseng was processed by using
microwave. Each of 200 mg of the ginseng dry extracts was added
to 1 mL of water in a 10-mL container of a microwave irradiator
(model no.: 908005) manufactured by CEM Company (Matthews,
NC, USA). The ginseng dry extract was irradiated with microwaves
in the sealed container at a temperature of 150C and a power of
100 W (a frequency of 2,455 MHz) for 60 min. The microwave-
irradiated ginseng dry extracts were freeze-dried to obtain
microwave-irradiated process products. A pressure for the micro-
wave irradiation was 20 atm.
2.4. Analysis of ginsenosides
Ginsenosides were analyzed by the comparison of retention
times and molecular weights with those of standard samples
[14,15]. Analytical reversed-phase HPLC system was composed of a
solvent degasser (Agilent, G1322A, Santa Clara, CA, USA), binary
pump (Agilent, G1312C), an autosampler (Agilent, G1329B) and
model 380 Evaporative Light Scattering Detector (ELSD) (Agilent).
ELSD conditions were optimized in order to achieve maximum
sensitivity: temperature of the nebulizer was set for 50C, and N2
was used as the nebulizing gas at a pressure of 2.0 bar. The Phe-
nomenex Luna C18 column (150 4.6 mm, 5 mm, Torrance, CA, USA)
was used, and the mobile phase consisted of a binary gradient of
solvent A (acetonitrile: water: 5% acetic acid inwater¼ 15:80:5) and
solvent B (acetonitrile: water ¼ 80:20) at a ﬂow rate of 1.0 mL/min.
The gradient ﬂow program was as follows: initial; 0% B, 6 min; 30%
B,18min; 50% B, 30min; 100% B, 37min; 100% B, 42min; 0% B. Low-
resolution electrospray ionisation (ESI)-MS data were measured
with an Agilent Technologies VS/Agilent 1100 system (Santa Clara,
CA, USA). The amounts of ginsenosides in samples were quantiﬁed
as reported previously [12]. The standard solutions containing 1e
50 mg of each ginsenoside were injected into the HPLC and all cali-
bration curves showed good linearity (R2 > 0.995). The analysis was
repeated two times for the veriﬁcation of repeatability.
2.5. Antiproliferative effect on three prostate cancer cell lines
Androgen-responsive LNCaP, androgen-insensitive DU145, and
PC3 prostate cancer cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA, USA). The cells were grown
in DMEM or RPMI1640 medium (Cellgro, Manassas, VA, USA)
supplemented with 10% fetal bovine serum (Gibco BRL, Carlsbad,
MD, USA), 100 units/mL penicillin and 100 mg/mL streptomycin and
incubated at 37C in a humidiﬁed atmosphere with 5% CO2. Ez-
cytox Cell viability assay kit (Itsbio, Seoul, Korea) was used to
determine cell viability. Brieﬂy, cells were seeded in 96-well plates
at a density of 1 104 cells/well and incubated for 24 h at 37C. Thecells were treated with different concentrations of compounds.
After incubation for 24 h, 10 mL of the kit reagent was added to each
well, and the cells were incubated for an additional hour. Cell
proliferationwasmeasured by scanning with amicroplate reader at
450 nm. Control cells were exposed to culture media containing
0.5% v/v dimethyl sulfoxide (DMSO).
2.6. Growth of cancer cell xenografts in athymic nude mice
All procedures involving the use of live animals as described in
this study were approved in May 2013 by the Institutional Animal
Care and Use Committee of the Korea Institute of Science and
Technology, Gangneung, Taiwan and strictly followed the National
Institutes of Health guidelines for humane treatment of animals.
Male athymic nu/nu mice, 4e5 wk of age, were obtained from
Orient Bio Co., Ltd. (Seongnam, Korea). Theywere exposed to a 12-h
light/12-h dark cycle, and had free access to water and normal diet
(38057, Agribrands Purina Korea, Seongnam, Korea) containing 10
kcal% fat for a period of 1 wk after arrival. Mice were housed under
aseptic conditions (positive air pressure in a designated mouse
room, with microisolator tops) and all mouse handling procedures
were carried out under a laminar ﬂow hood. DU145 cells (5  106
cells/100 mL PBS) were injected subcutaneously into the right and
left ﬂank of the mice. Two wks after inoculation, mice were
randomly grouped according to body weight and tumor size and
started feeding on the experimental diets. They were fed on either
normal diet (vehicle) or diet containing 0.1% MG (MG group)
throughout the experimental period (approximately equivalent to
the oral dose of 200 mg/kg). The maximum and minimum di-
ameters of the tumor were measured once/wk using a slide caliper.
Tumor volume was calculated using the formula [p/6  d3], where
d is the mean diameter. Body weight of each mouse was measured
twice/wk. At the end of the experiment, the mice were killed with
CO2 overdose followed by cervical dislocation.
2.7. Western blotting analysis
Cells (8  105 cells) grown in 60-mm dishes were treated with
the indicated concentration of samples for 24 h.Whole-cell extracts
were then prepared according to the manufacturer’s instructions
using RIPA buffer (Cell Signaling) supplemented with 1  protease
inhibitor cocktail and 1mM phenylmethylsulfonyl ﬂuoride (PMSF).
Proteins (whole-cell extracts, 30 mg/lane) were separated by elec-
trophoresis in a precast 4e15% Mini-PROTEAN TGX gel (Bio-Rad,
Hercules, CA, USA) blotted onto PVDF transfer membranes and
analyzed with epitope-speciﬁc primary and secondary antibodies.
Bound antibodies were visualized using ECL Advance Western
Blotting Detection Reagents (GE Healthcare, Buckinghamshire, UK)
and a LAS 4000 imaging system (Fujiﬁlm, Tokyo, Japan).
2.8. Statistical analysis
Statistical signiﬁcance was determined through analysis of
variance followed by a multiple comparison test with a Bonferroni
adjustment. A p value < 0.05 was considered statistically signiﬁ-
cant. The analysis was performed using SPSS version 19.0 (SPSS Inc.,
Chicago, IL, USA).
3. Results and discussion
Methods for improving the anticancer effect of ginseng by con-
version of ginsenosides, the major active components of ginseng, by
microwave-assisted high-temperature and high-pressure process-
ing has been developed. To quantify the ginsenosides, the HPLC
condition was optimized by changing the elution gradient. The
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in Figs. 1B and C. The processing conditions for microwave treat-
ment of ginseng extracts were optimized [13] and the conditions
resulting in the highest generation of ginsenosides Rg3, Rg5, and
Rk1were selected. As shown in Figs. 1B and C, in the ginseng extract
that was microwave-assisted processed at 150C for 60 min, the
contents of ginsenosides Re, Rb1, Rc, and Rb2 gradually decreased
whilst the contents of ginsenoside Rg3, Rk1, and Rg5 increased.
To conﬁrm the anticancer effect of MG, it was tested in three
human prostate cancer cell lines (DU145, LNCaP, and PC-3 cells). MG
inhibited proliferation of DU145, LNCaP, and PC-3 cells more strongly
than WG in a dose-dependent manner as shown in Fig. 2. The half-
maximal inhibitory concentration (IC50) values were determined
by interpolation from the doseeresponse curves. Antiproliferation
results for the three prostate cancer cell lines treated with ginseng
extracts showed that MG had IC50 values of 48 mg/mL, 74 mg/mL, and
62 mg/mL in PC-3, DU145, and LNCap cells, respectively.
The roles of DNA damage, autophagy, and apoptosis have highly
researched and reviewed for cancer prevention in ginseng research
[15e19]. PARP inhibitors are currently undergoing clinical evalua-
tion in advanced sporadic prostate cancer both as a single agent and
in combination with multiple chemopreventive agents. PARP in-
hibitors may be the ﬁrst of a generation of novel therapeutic stra-
tegies that improve or possibly avoid the use of hormone therapy
with prostate cancer [20]. After treatment with 100 mg/mL MG, the
expression of apoptosis-related proteins PARP (cleaved PARP)
increased slightly (Fig. 3).Fig. 2. Comparison in the effect of ginseng extracts on the proliferation of human prostate ca
indicated concentrations of white ginseng (WG) and microwave-irradiated processed ginse
complete medium containing indicated concentrations of WG and MG (12.5e200 mg/mL) fo
indicated concentrations of WG and MG (12.5e200 mg/mL) for 24 h. Ez-cytox Cell viability as
deviation (*p < 0.05, n ¼ 3).Superoxides, hydroxyl radicals, and peroxides are reactive oxygen
species (ROS) that are generated during normal metabolic processes
in cells. However, ROS that generated either endogenously or from
external sources [21]playa critical role in regulating severalbiological
phenomena. The increased ROS generation not only has traditionally
been associated with tissue injury or DNA damage, but also plays an
essential role in several cellular processes associated with neoplastic
transformation and aberrant proliferation and growth [22,23]. Gin-
senosides have reported to inhibit cancer cell proliferation by
inducing gene or protein expression of the cell cycle regulatory pro-
tein p21 and arresting cell cycle progression by inducing apoptosis
through activation of caspases via a bcl-2-insensitive pathway and/or
by inhibiting themitogen-activated protein kinase signaling pathway
in cancer cells [24e27]. Co-treatment of cells withMG resulted in the
activation of the inactive 32-kDa caspase-3 precursor to the cleaved
p17 subunit, indicating that caspase-3 was activated during drug-
induced apoptosis (Fig. 3).
The pH2AX foci mark sites of double-strand DNA breaks and
subsequently recruit multiple proteins involved in DNA strand
break repair and damage signaling [28,29]. The pH2AX is typically
deactivated at the completion of proper DNA repair. In genomically
unstable cells with dysfunctional DNA damage, pH2AX remains
activated and cells continue to replicate without proper DNA repair
[30]. Therefore, the expression of pH2AX in PC-3 cells after MG
treatment was investigated. As shown in Fig. 3, protein expression
of pH2AX in PC-3 cells was markedly increased after MG treatment
in a dose-dependent manner.ncer cells. (A) PC-3 prostate cancer cells were exposed to complete medium containing
ng (MG) (12.5e200 mg/mL) for 24 h. (B) DU145 prostate cancer cells were exposed to
r 24 h. (C) LNCap prostate cancer cells were exposed to complete medium containing
say kit was used to determine cell viability. The data are presented as mean  standard
Fig. 3. MG decreases the proliferative and antiapoptotic proteins expression. PC-3 cells were exposed to vehicle (0.1% dimethyl sulfoxide) or indicated concentrations of MG (50 mg/
mL and 100 mg/mL) for 24 h. Cell lysates from each sample were used for Western blot analyses performed with antibodies directed against poly (ADP-ribose) polymerase (PARP),
cleaved caspase-3, LC3, and pH2AX. Glyceraldehyde 3-phosphate dehydrogenase was used as a loading control. The data are presented as mean  standard deviation (*p < 0.05,
n ¼ 3).
J Ginseng Res 2016;40:62e6766Autophagy, a cellular process responsible for the degradation of
cytoplasmic components through an autophagosomalelysosomal
pathway, has been implicated to play a key role in cancer initiation
and progression. Microtubule-associated protein light chain 3 (LC3)
is widely used to monitor autophagosome formation. The conver-
sion of LC3-I (18 kDa) to LC3-II (16 kDa) and its translocalization
from the cytosol to autophagosomes is a reliable marker of auto-
phagy [31]. Western blot analysis for LC3 showed a remarkable in-
crease in LC3-II in response to MG treatment in a concentration-
dependent manner (Fig. 3). Thus, these results suggest that MG
induces autophagic cell death as well as apoptosis in PC-3 cells.
To evaluate the anticancer effect of MG in vivo, we used the
growth of human cervical cancer cell xenografts in athymic nude
mice as a model. Fig. 4 shows the effect of MG on the growth of
human cervical cancer HeLa cells in athymic nude mice. A signiﬁ-
cant increase in tumor growth volume was observed during the
course of and at the end of experimentation in vehicle-treatedmice
(Fig. 4). However, treatment with MG signiﬁcantly suppressedtumor growth over the 5-wk experimental period (Fig. 4B). These
data indicate that MG suppresses prostate cancer growth in vivo by
promoting cancer cell death, likely resulting from increased in-
duction of apoptosis and autophagy.
In summary, the microwave-irradiated processed ginseng has a
higher content of ginsenosides Rg3, Rg5, and Rk1, and thus has an
increased medicinal effect from them. It was shown that MG sup-
pressed the growth of human prostate cancer cells both in vitro and
in vivo. This growth suppression by MG is associated with the in-
ductions of apoptotic cell death and autophagy. Therefore, heat
processing by microwave-assisted irradiation is a useful method to
enhance the apoptotic effect of ginseng due to the increased con-
tent of ginsenosides Rg3, Rg5, and Rk1.Conﬂicts of interest
The authors declare no conﬂicts of interest in this work.
BA
Fig. 4. Effect of microwave-assisted processed ginseng on the growth of human
prostate cancer PC-3 cells in athymic nude mice. (A) Representative photographs of
tumors in athymic nude mice. (B) The changes in tumor growth. DU145 cells (5  106
cells/100 mL PBS) were injected subcutaneously into the right and left ﬂank of the mice.
Twowks after inoculation, mice were randomly grouped according to body weight and
tumor size and started to feed the experimental diets.
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